Two Approvals, One Mission—Sakar’s Oncology Push Finds European Traction

Unknown Apr 02, 2026 1,250 Views

New Approval Bolsters Oncology Franchise Sakar Healthcare Ltd. got its second Marketing Authorization (MA) from the EU for an oncology injection in colorectal cancer and its first EU approval in April 2025 for a product that is utilized to treat breast, lung, and prostate cancer. The new clea...